Voya Investment Management LLC Acadia Pharmaceuticals Inc Transaction History

Voya Investment Management LLC

$79.9 Billion
Q3 2024

A detailed history of Voya Investment Management LLC transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Voya Investment Management LLC holds 46,863 shares of ACAD stock, worth $762,461. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,863

Previous 52,249 10.31%

Holding current value

$762,461

Previous $849,000 15.08%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $81,544 - $103,088	-5,386 Reduced 10.31%	46,863 $721,000
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $2.55 Million - $3.21 Million	-174,532 Reduced 76.96%	52,249 $849,000
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $1.02 Million - $1.78 Million	-57,563 Reduced 20.24%	226,781 $4.19 Million
Q4 2023 Feb 14, 2024	BUY	$20.78 - $31.77 $595,076 - $909,797	28,637 Added 11.2%	284,344 $8.9 Million
Q3 2023 Nov 14, 2023	BUY	$20.84 - $33.47 $5,668 - $9,103	272 Added 0.11%	255,707 $5.33 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $251,371 - $362,229	14,122 Added 5.85%	255,435 $6.12 Million
Q1 2023 May 15, 2023	SELL	$16.32 - $20.92 $4,080 - $5,230	-250 Reduced 0.1%	241,313 $4.54 Million
Q4 2022 Feb 14, 2023	BUY	$14.2 - $18.63 $81,863 - $107,401	5,765 Added 2.44%	241,563 $3.85 Million
Q3 2022 Mar 03, 2023	SELL	$14.11 - $18.27 $81,344 - $105,326	-5,765 Reduced 2.39%	235,798 $3.86 Million
Q3 2022 Nov 14, 2022	SELL	$14.11 - $18.27 $1.2 Million - $1.56 Million	-85,128 Reduced 26.53%	235,798 $3.86 Million
Q2 2022 Aug 15, 2022	BUY	$13.01 - $27.22 $3.55 Million - $7.42 Million	272,673 Added 565.09%	320,926 $4.52 Million
Q1 2022 May 16, 2022	BUY	$20.94 - $27.5 $2,198 - $2,887	105 Added 0.22%	48,253 $1.17 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $6,195 - $9,996	369 Added 0.77%	48,148 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$15.78 - $24.77 $10,162 - $15,951	644 Added 1.37%	47,779 $794,000
Q2 2021 Aug 16, 2021	SELL	$19.4 - $27.42 $634,690 - $897,072	-32,716 Reduced 40.97%	47,135 $1.15 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $704,613 - $1.55 Million	28,162 Added 54.48%	79,851 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $24,295 - $33,619	-592 Reduced 1.13%	51,689 $2.76 Million
Q3 2020 Nov 16, 2020	BUY	$36.42 - $57.0 $194,664 - $304,665	5,345 Added 11.39%	52,281 $2.16 Million
Q2 2020 Aug 14, 2020	SELL	$39.26 - $52.73 $535,427 - $719,131	-13,638 Reduced 22.51%	46,936 $2.28 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $17,692 - $26,200	-559 Reduced 0.91%	60,574 $2.56 Million
Q4 2019 Feb 14, 2020	BUY	$36.21 - $51.4 $678,539 - $963,184	18,739 Added 44.2%	61,133 $2.62 Million
Q3 2019 Nov 14, 2019	SELL	$22.22 - $44.01 $59,371 - $117,594	-2,672 Reduced 5.93%	42,394 $1.53 Million
Q2 2019 Aug 14, 2019	SELL	$23.32 - $28.12 $13,572 - $16,365	-582 Reduced 1.27%	45,066 $1.21 Million
Q1 2019 May 15, 2019	BUY	$16.17 - $27.38 $85,814 - $145,305	5,307 Added 13.16%	45,648 $1.23 Million
Q4 2018 Feb 14, 2019	BUY	$14.32 - $22.92 $35,126 - $56,222	2,453 Added 6.47%	40,341 $652,000
Q2 2018 Aug 14, 2018	SELL	$15.07 - $22.34 $853,172 - $1.26 Million	-56,614 Reduced 59.91%	37,888 $579,000
Q1 2018 May 15, 2018	BUY	$22.47 - $32.33 $213,330 - $306,941	9,494 Added 11.17%	94,502 $2.12 Million
Q4 2017 Feb 14, 2018	BUY	$26.84 - $39.14 $1.01 Million - $1.47 Million	37,561 Added 79.16%	85,008 $2.56 Million
Q3 2017 Nov 14, 2017	BUY	$29.49 - $38.37 $1.4 Million - $1.82 Million	47,447	47,447 $1.79 Million

Others Institutions Holding ACAD

# of Institutions

280

Shares Held

156M

Call Options Held

901K

Put Options Held

314K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.63B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Acadia Pharmaceuticals Inc Transaction History